Boston Partners Bristol Myers Squibb CO Transaction History

Boston Partners

$80.6 Billion
Q3 2024

A detailed history of Boston Partners transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Boston Partners holds 3,361,391 shares of BMY stock, worth $198 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

3,361,391

Previous 3,378,829 0.52%

Holding current value

$198 Million

Previous $140 Million 23.97%

% of portfolio

0.22%

Previous 0.18%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$39.66 - $51.75 $691,591 - $902,416	-17,438 Reduced 0.52%	3,361,391 $174 Million
Q2 2024 Aug 13, 2024	SELL	$40.25 - $52.99 $282 Million - $372 Million	-7,016,591 Reduced 67.5%	3,378,829 $140 Million
Q1 2024 May 13, 2024	SELL	$47.98 - $54.4 $162 Million - $183 Million	-3,368,473 Reduced 24.47%	10,395,420 $564 Million
Q4 2023 Feb 07, 2024	SELL	$48.48 - $57.85 $172 Million - $205 Million	-3,550,695 Reduced 20.51%	13,763,893 $706 Million
Q3 2023 Nov 07, 2023	SELL	$57.89 - $64.73 $5.16 Million - $5.77 Million	-89,166 Reduced 0.51%	17,314,588 $1 Billion
Q2 2023 Aug 10, 2023	SELL	$63.71 - $70.74 $43.1 Million - $47.9 Million	-676,814 Reduced 3.74%	17,403,754 $1.11 Billion
Q1 2023 May 09, 2023	BUY	$65.71 - $74.53 $282 Million - $319 Million	4,286,479 Added 31.07%	18,080,568 $1.25 Billion
Q4 2022 Feb 07, 2023	BUY	$68.48 - $81.09 $248 Million - $294 Million	3,627,705 Added 35.68%	13,794,089 $992 Million
Q3 2022 Nov 09, 2022	BUY	$0.13 - $76.84 $670,959 - $397 Million	5,161,226 Added 103.12%	10,166,384 $725 Million
Q2 2022 Aug 10, 2022	BUY	$72.62 - $79.98 $5.06 Million - $5.58 Million	69,722 Added 1.41%	5,005,158 $385 Million
Q1 2022 May 10, 2022	SELL	$61.48 - $73.72 $700,195 - $839,597	-11,389 Reduced 0.23%	4,935,436 $361 Million
Q4 2021 Feb 04, 2022	BUY	$53.63 - $62.52 $42.2 Million - $49.2 Million	786,945 Added 18.92%	4,946,825 $308 Million
Q3 2021 Nov 05, 2021	BUY	$59.17 - $69.31 $246 Million - $288 Million	4,159,880 New	4,159,880 $246 Million
Q2 2019 Aug 09, 2019	SELL	$44.62 - $49.34 $1.3 Million - $1.44 Million	-29,100 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $1.61 Million - $1.81 Million	29,100 New	29,100 $1.81 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

News

Stay updated on Boston Partners with notifications on news.

Account